Neuren Pharmaceuticals | NEU - Capital Social e Reservas

Preço das Ações
12.47
Mudança Diária
0.01 0.08%
Mensal
3.66%
Anual
0.24%
Q2 Previsão
12.10




Capital Social e Reservas Alterar Data
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.15M 650K 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Clinuvel Pharmaceuticals AUD 249.02M 8.21M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Genetic Signatures AUD 44.09M 6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Medical Developments International AUD 54.77M 335K 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organon & Co USD 752M 154M 2025-12
Paradigm Biopharmaceuticals AUD 6M 15.18M 2025-12
PYC Therapeutics AUD 147.18M 22.82M 2025-12
Starpharma Holdings AUD 21.48M 2.48M 2025-12
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12